Skip to Content

202 (Darifenacin hydrobromide extended-release 7.5 mg)

Pill imprint 202 has been identified as Darifenacin hydrobromide extended-release 7.5 mg.

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Darifenacin hydrobromide extended-release
Imprint:
202
Strength:
7.5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Torrent Pharmaceuticals Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide